Methodological issues in the design of primary prevention trials.

IARC scientific publications

Volumn , Issue 136, 1996, Pages 7-12

  Gaziano, J M ^a   Hennekens, C H ^a   Buring, J E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CAROTENE; PLACEBO;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; HUMAN; METHODOLOGY; NEOPLASM; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTICARCINOGENIC AGENTS; BETA CAROTENE; CHEMOPREVENTION; DOUBLE-BLIND METHOD; HUMANS; NEOPLASMS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS;

EID: 0029690182     PISSN: 03005038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)